MLXIPL and metabolic dysfunction-associated steatotic liver disease: We also analysed the MLXIPL expression in the liver tissue of HFD‐induced NAFLD and found that MLXIPL expression was significantly elevated at weeks 16 and 24 of NAFLD development at both protein (Figure 4B) and mRNA (Figure 4C) levels.